Bitterly opposed old guard at Takeda wages a last-ditch fight to block 'foreign blood's' $62B Shire buyout
As Takeda CEO Christophe Weber pulls the strings for director support in the $62 billion acquisition of Shire, a small group of ex-Takeda employees have put down their foot and vowed to block the proposed deal.
Comprising 130 members, the group holds 1% of the Japanese drugmakers’ shares. To sway the final decision, they need a third of shareholders to also vote no. Their current targets are domestic retail investors and overseas institutional investors who own 25 percent and 35 percent of Takeda shares respectively, an anonymous source told Reuters.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
